Tolfenamic acid in ankylosing spondylarthritis: a double-blind comparison to indomethacin.


The randomized, double-blind trial was carried out with 50 patients suffering from ankylosing spondylarthritis and belonging all to type B27 in the HLA system. Tolfenamic acid (600 mg daily) was effective as judged by subjective and numerous objective parameters and was preferable to indomethacin (75 mg daily). Indomethacin caused side effects more… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics